Upload
lyhuong
View
214
Download
0
Embed Size (px)
Citation preview
Potential Conflict of Interest Disclosure
•Board of Trustees American College of Cardiology
•Writing Committee Multi-Society National Systems of Care
•Co- PI of COAPT Trial of Abbott Vascular
•Steering Committee Intrepid Trial of Medtronic
•Co-PI of the PARTNER 3 Trial of Edwards Lifesciences
How many of the 2,100 Cath Labs in the US Should be Treating Him ?
This is Your Frail, Elderly Father !
Barlow’s Myxoid Degeneration
5
• Thickened Leaflets – “aneurysmal pockets” • Redundant elongated chords • Bileaflet prolapse and billowing • Massively dilated annulus • Atrialized attachment of posterior leaflet • Often highly calcified annulus
How Many of the 1,150 Cardiac Surgery Programs Can Repair This Valve ?
How Many of the 272 Cath Labs Performing MitraClip Realize This is Not a Good MitraClip Case?
This Is Your Brother
This is Your 90 Year Old Mother With Severe AS with LVOT Ca++ and MAC
How Many of the 560 TAVR Programs Would You Let Her be Treated In?
2017 AATS/ACC/ASE/SCAI/STS Expert Consensus System of Care Draft Documents
(Operator and Institutional TAVR Requirements and Optimizing Care for VHD Patients)
7
Misconceptions About a Valve Network It’s all about TAVR
It’s an exclusive club
It will limit access to care
National Systems of Care
Cancer Trauma Stroke Bariatric
Surgery STEMI
1960 1976 2001 2005 2006/2007
NIH
American
College of
Surgeons
Brain Attack
Coalition
American
Society of
Bariatric
Surgery
American
College of
Surgeons
American College
of Cardiology
(D2B Alliance)
American Heart
Association
(Mission:
Lifeline)
NIH
Cancer
Centers
ACS
Trauma
Centers
Brain Attack
Coalition
Stroke Centers
ASBS
ACS
Bariatric
Centers
ACC/
AHA
STEMI
Basic Laboratory Cancer
Center
Cancer Centers
Comprehensive Cancer
Center
Level I
Level II
Level III
Level IV
Acute Stroke-
Ready hospital
Primary Stroke
Center
Comprehensive
Stroke Center
Bariatric
Surgery Center
of Excellence
STEMI-referral
hospital
(non-PCI capable)
STEMI-receiving
hospital
(PCI-capable)
National Systems of Care
Systems of Care for VHD Rationale
The cost and complexity of diagnosis and treatment of VHD are increasing.
It is not feasible for all cardiac centers to provide the full suite of resources, infrastructure and expertise to care for patients across the entire spectrum of VHD.
The guiding principle is to optimize the care of the individual patient by providing access to the right care at the right place and time while respecting his/her preferences and values.
ESC/EACTS Comprehensive Heart Valve Centre Standards
Consideration of the volume-outcome relationship for surgical and transcather procedures is a complex, nuanced and challenging process.
“Ability to demonstrate good results is more important than mandating volume targets.”
“It is likely that [good outcomes for MV surgery] will not be attained without high individual surgeon and centre volume.”
“Large registries are expected to inform future guidance on minimal [TAVR] volumes…”
Chambers JB et al. EHJ 2017:38:2177-83
Minimum
Heart valve clinic
Multi-modality imaging
Procedures available
MDT
Processes
Data review
ESC/EACTS Comprehensive Heart Valve Centre Standards
Chambers JB et al. EHJ 2017:38:2177-83
Procedures
TAVR, Mitral Clip
All HV replacements
MVRp, TVRp
Surgery for aortic root and ascending aorta
AF ablation
Links with other centers
A Spoke-and-Hub or Tiered System of Care for Patients with Valvular Heart Disease?
CVC
PVC
PVC
Primary Valve Center Comprehensive Valve Center
Comprehensive (Level I) Valve Center Primary (Level II) Valve Center
Interventional procedures TAVR – TF TAVR – TF
BAV BAV
TAVR – alternative access
Valve-in-valve procedures
MitraClip
Paravalvular leak closure
PBMV
Surgical procedures Isolated AVR Isolated AVR
Valve-sparing aortic root procedures
AVR/Myomectomy
Root enlargement with AVR
Mitral repair for primary MR (P2 pathology) Mitral repair for primary MR (P2 pathology)
Mitral repair for complex primary MR (Barlow’s and bileaflet prolapse)
Multivalve operations
Re-operative valve surgery
Isolated tricuspid valve repair or replacement
Considerations
Quality Access
Mortality Disparities
Morbidity Geography
Durability Wait Times
Cost Follow-Up
Heart Valve
Centers
Competition, Restricted Referral
Lines, COI, AMC vs. Community,
Cultures, Payment Models Courtesy P. O’Gara
Questions •Does This Make Sense?
•Is there a volume outcome relationship for medical procedures?
•Is volume an appropriate surrogate for quality?
•How do you balance quality outcomes with access to care?
•What are the barriers of access to care
•Can every center treat every patient and do it well?
Premises There is a volume outcome relationship in medical procedures
The more complex the procedure, the greater that relationship
The principle is not only about the performance of the procedure but also about the care ecosystem: ◦ Diagnostic/imaging expertise ◦ Multi-disciplinary team/shared decision-making ◦ Patient selection ◦ Post-procedure care
All this has to be balanced against adequate access to care
Medical Conditions and Procedures for Which a Volume-Outcome Association Has Been Shown
MI, CVA, Heart Failure, Pneumonia
CABG, AAA Repair, CEA
MVRR, AVR
PCI, ICD
TAVR
10 Volume Pledge Procedures
Volume
O
utc
om
e
Primary MR Repair in NY State
• Wide variability • Median volume = 10 • Higher surgeon volumes
associated with better outcomes
• Re-operation less common with > 25 repairs per year
Chikwe J et al. JACC 2017; 69:2397-1706
Criteria • MV surgery volumes (surgeon and center) • Expert peri-procedural imaging • Transparency regarding outcomes: repair rates, mortality,
stroke, durability
Outcome Rate
Mortality < 1%
Major Complication < 2%
Repair rate > 90% (> 95% for P2 prolapse)
Residual MR > 2+ < 5% at 5 years
Re-operation rate
PMVL < 1% per year
AMVL < 2% per year
Standards for MV Repair for Primary MR
Chambers JB et al. EHJ 2017:38:2177-83
Recommendation COR LOE
MV repair is reasonable in asymptomatic
patients with chronic severe primary MR (stage
C1) with preserved LV function (LVEF >60% and
LVESD <40 mm) in whom the likelihood of a
successful and durable repair without residual
MR is >95% with an expected mortality <1%
when performed at a Heart Valve Center of
Excellence
IIa B
AHA/ACC 2017 Valve Disease Guideline
Nishimura RA et al. JACC 2017 doi: 10.1016/j.jacc.2017.03.011.
With experience (case volume) the risk of dying is reduced from 3.57% to 2.15%.
Dying During or Immediately After TAVR
Of 16 252 index TAVR procedures, 663 (4.1%), 3067 (18.9%), and 12 522 (77.0%) were performed at low-, medium-, and high-volume hospitals, respectively.
Thirty-day readmission rates were significantly lower in high-volume compared with medium-volume (adjusted odds ratio, 0.76; 95%CI, 0.68-0.85; P < .001) and low-volume (adjusted odds ratio, 0.75; 95%CI, 0.60-0.92; P = .007) hospitals
Khera et al. JAMA Cardiol. 2017;2(7):732-741.
Valve Centers/Million Population 1.5
1.25
0.8
0.6 0.5
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
US Germany Japan Canada UK
49
ACCF/STS
Tiered Site Certification*
• Case mix • Volume and Outcomes • Research Infrastructure • IRB/Contracting Efficiency • Clinical Infrastructure • Dataset Needs vs. Capabilities
Tier Criteria
Databases/Registries ACC NCDR
CathPCI ICD IMPACT LAAO AF Ablation PVI
STS National Database STS ACS STS CHD STS Thoracic Surgery
Joint STS and ACC TVT Aortic TVT Mitral TVT Tricuspid
*Sites apply for certification level desired for each database. Free to use certification level for each database in marketing.
Dataset Complexity & Need for Multi-
Stakeholder Support
Registry Sustainability – Fit-to-Purpose Infrastructure
Shared Benefits of Multi-Stakeholder Partnerships
John Laschinger FDA CDRH
Goal of Specialized Valve Center Care
Optimize the care of the individual patient by insuring access to the right care, in the right place, at the right time while respecting his/her values and preferences
Underlying Principles for Development of a Valve System of Care
•Optimize the care of the patient with valvular heart disease
•Increasing complexities of diagnosis and therapy require increasing levels of experience and expertise.
•Institutional commitment to excellence in care with the provision of appropriate resources to provide this care
•The Heart Valve Team utilizing a multidisciplinary approach
•Shared decision making with patient choice should be a primary goal, with clarity to the consumer
Underlying Principles for Development of a Valve System of Care
•Participation in national registries and research trials
•Participation in quality improvement initiatives
• On-going analysis of process and outcomes
•Transparency of outcomes-public reporting
•On-going education of the valve team as well as to the lines of referral
If recommended thresholds for operator and site TAVR volumes are instituted, there will be a dramatic reduction in the number of hospitals providing TAVR
# TAVR hospitals reduced from 475 in 2016, to 263
after thresholds
45%
Source: FY2016 MedPAR
Current After Thresholds
Analysis By Edwards Lifesciences
Is It Time For Valve Centers of Excellence? Summary
•The best initial system is probably a tiered system of valve centers
•Valve centers need to have commitment to structure, processes and outcomes
•There is a similar initiative in Europe
•This isn’t just about performing a procedure
•It’s about a comprehensive approach to treating a disease that maximizes the chance of a patient getting… … the right procedure
…at the right place
…at the right time
… with the best possible outcome